Antiarrhythmic Properties of Long-Term Treatment with Matrine in Arrhythmic Rat Induced by Coronary Ligation
standard limb lead II ECG was recorded for 2 h after operation. The incidence of arrhythmias and the survival rate were registered and evaluated, and the criteria of arrhythmias was very similar to that described previously, 12, 13) as follows: 0ϭno arrhythmia; 1ϭϽ10 s premature ventricular contraction (PVC) and/or VT; 2ϭ11-30 s PVC and/or VT; 3ϭ 31-90 s PVC and/or VT; 4ϭ91-180 s PVC and/or VT, Ͻ10 s reversible VF; 5ϭϾ180 s PVC and/or VT, Ͼ10 s reversible VF, 6ϭirreversible VF. In all experiments, irreversible ventricular fibrillation was the only cause of death.
Measurements of Hemodynamic Function Three months after MI, rats were anesthetized for terminal study. Left ventricular end diastolic pressure (LVEDP), and time derivatives of pressure was measured during contraction (ϩdP/dt) and relaxation (ϪdP/dt) recorded on a polygraph as described previously. 12) Isolation of Ventricular Myocytes Single ventricular myocyte was isolated enzymatically as previously described in detail. 14, 15) Three months after surgery rats of four groups were anaesthetized and the hearts were quickly removed. Then hearts were rapidly washed in cool, oxygenated Tyrode solution in mM: 126 NaCl, 5.4 KCl, 10 N-(2-hydroxyethyl)-piperazine-NЈ-2-ethanesulfonic acid (HEPES), 0.33 NaH 2 PO 4 · 2H 2 O, 1.0 MgCl 2 · 6H 2 O, 1.8 CaCl 2 and 10 glucose, pH was adjusted to 7.4 with NaOH, and mounted to a Langendorff perfusion apparatus and perfused retrogradely via the coronary circulation. The heart was perfused with standard Tyrode's solution for 5 min, then switched to Ca 2ϩ -free Tyrode's solution until it stopped beating, followed by perfusion with the same solution containing collagenase II (7.0 mg · 50 ml
Ϫ1
) and BSA. The peri-ischemic zone ventricular tissue was shaved and minced in the storage solution and filtered. The freshly isolated myocytes were gently centrifuged and resuspended in the KB medium (in mM: 70 glutamic acid, 15 taurine, 30 KCl, 10 KH 2 PO 4 , 10 HEPES, 0.5 MgCl 2 · 6H 2 O, 10 glucose and 0.5 EGTA; pH 7.4 with KOH). All solutions were gassed with 100% oxygen and warmed to 37Ϯ0.5°C. Only single rod-shaped, Ca 2ϩ -tolerant, and quiescent cell with clear cross-striation was selected for electrophysiological recording and intracellular calcium measurement.
Whole-Cell Patch-Clamp Recording Currents were recorded in the whole-cell voltage-clamp mode and action potentials (APs) were recorded in the current-clamp mode, with an Axopatch-200B amplifier (Axon Instruments). Patch-clamp techniques have been described in detail elsewhere. 14, 15) To measure K ϩ currents, borosilicate glass electrodes had tip resistance of 2-4 MW when filled with pipette solution. For K ϩ currents and action potential recordings, myocytes were superfused with a standard Tyrode solution. The pipette solution for K ϩ current recordings contained in mM: 20 KCl, 110 potassium asparate, 1 MgCl 2 , 5 Na 2 -ATP, 10 EGTA, and 10 HEPES, pH adjusted to 7.20 with KOH. The internal pipette solution for APs recording contained the same components as for K ϩ currents recording, except that EGTA was reduced to 0.05 mM. For outward K ϩ current recordings, NaCl was replaced by choline chloride in the external solution to eliminate the fast I Na . CdCl 2 (1.0 mM) was added to the external solution to inhibit I Ca . The capacitance and series resistance (Rs) were compensated. Recordings were low-pass filtered at 1 kHz. Junction potentials were zeroed before formation of the membrane-pipette seal in Tyrode solution. All experiments were performed at room temperature (19-21°C) .
Western Blot To determine the protein expression level of Kir2.1 and Kv4.2, we performed standard Western blot techniques as described previously by our laboratories. 12) Briefly, equal amounts of protein (60 mg) were subjected to 10% SDS-PAGE and blotted to nitrocellulose. The blots were blocked in 5% nonfat milk dissolved in PBST for 3 h, then probed with Kir2.1 (Santa Cruz) and Kv4.2 (Alomone) antibodies, or GAPDH (Kangcheng Inc.) in PBST, and reacted with the second antibody (Alexa Fluor) in PBST. Immunoreactive bands were captured by the Odyssey System (LI-COR Bioscience, Lincoln, U.S.A.). Western blot bands were quantified using Odyssey v1.2 software and normalizing GAPDH as an internal control.
[Ca
] i fluorescence measurement in cardiomyocytes has been described previously.
16) The peri-ischemic zone ventricular myocytes derived from shamoperated rats were referred to as sham cells whereas those derived from MI rats were referred to as MI myocytes. Isolated single ventricular myocytes were adhered then rinsed with normal Tyrode's solution and incubated with a working solution containing Fluo-3/AM (20 mM) and Pluronic F-127 (0.03%) at 37°C for 45 min. The fluorescent change of the Fluo-3/AM loaded cell was detected by confocal laser scanning microscope (Fluoview-FV300, Olympus, Japan) with 488 nm for excitation from an Argon ion laser and 530 nm for emission under inverted microscope with 20ϫ objective. All [Ca 2ϩ ] i measurements were made under steady-state conditions stimulating by KCl. Sixty micromolar KCl was added between 2nd and 3rd scan and the fluorescent intensities before (FI 0 ) and after (FI) drug administration were both recorded. The change of [Ca 2ϩ ] i was represented with ratio of fluorescence intensity (FI/FI 0 ). Area under the curve of [Ca 2ϩ ] i values were determined using the "Area Below Curves" function in Sigma Plot 9.0. Only the cell with rod shaped and visible striations was used for experiments.
Statistical Analyses Data are presented as the meanϮ S.E.M. and analyzed by GraphPad Prism 5.0, pCLAMP 8.0 and Sigmaplot 9.0 software. Chi-square analysis was used to compare incidence of arrhythmia and mortality among different groups. Kruskal-Wallis analysis was used to compare arrhythmia score. Statistical comparisons (performed using analysis of variance (ANOVA) followed by Bonferroni's multiple comparison tests or Dunnett's method) were used as appropriate to evaluate data among groups. A two-tailed pϽ 0.05 was considered to be a statistically significant difference.
RESULTS

Long-Term Effects of Matrine and Amiodarone on Arrhythmic Rats
Induced by MI Electrical disorders were observed after operation in 2 h. Arrhythmias, mainly of VT defined as a run of rapid ventricular deflections lasting longer than 30 s and reversible VF, was observed in the MI rats (Fig.  1A) . The VT often predisposed to VF leading to sudden death. The ECG clearly showed runs of polymorphic VT and VF in MI rats. Cumulative arrhythmic durations and arrhythmia scores in MI group were significantly higher than those in sham-operated group (pϽ0.05, nϭ30). However, both of parameters in AmioϩMI 50 mg/kg and MatϩMI 30 mg/kg groups were decreased compared with those in MI group (Figs. 1B, C). But, matrine 15 mg/kg had no obvious effect on arrhythmia score and arrhythmia duration in MI rats. Mortality were comparable among long-term MI, AmioϩMI, MatϩMI 30 mg/kg animals (63%, 37%, 33%, nϭ30, respectively). Mortality in MI group was increased obviously. As illustrated in Fig. 1D , both matrine and amiodarone reduced the incidence of sudden death in myocardial infarction rats (pϽ0.05, nϭ30).
In Vivo Hemodynamic Parameters Hemodynamic parameters measured in the four groups of rats were shown in Table 1 . Compared with the sham animals, heart rate (HR) was significant decreased in MI group. Most dramatic changes were seen in left ventricular end diastolic pressure (LVEDP), ϩdP/dt and ϪdP/dt values of MI rats. As shown in Table 1 , matrine 30 mg/kg and amiodarone treatment significantly lowered LVEDP in rat after MI (pϽ0.05, nϭ8). The increase in LVEDP and the decrease both in ϩdP/dt and ϪdP/dt were also prevented in the MatϩMI group. Matrine improved the hemodynamic function of long-term ischemic hearts.
Effects of Matrine and Amiodarone on Action Potential Duration Prolongation Induced by MI in Rat Ventricular Cell Action potentials were recorded in the currentclamp mode. APD at 50% and 90% repolarization (APD 50 and APD 90 ) were used to describe APD changes. APD 50 (50.0Ϯ1.6 ms) and APD 90 (65.3Ϯ1.9 ms) in long-term MI cells were all significantly prolongated (pϽ0.05, nϭ18). Matrine significantly shortened APD 50 and APD 90 compared with MI, and APD were nearly recovered to the normal value in MatϩMI group (data not shown), while amiodarone prolonged APD at 50% and 90% repolarization in MI rats (Fig.  2B, pϽ0.05, nϭ18) .
Long-Term Effects of Matrine and Amiodarone on Transient Outward I to and Kv4.2 Protein I to was the predominant repolarizing potassium current in rat ventricular myocytes. I to representative current traces from sham, MI, AmioϩMI, and MatϩMI groups were shown in Fig. 3A . Peak current density (I peak ) was reduced in MI myocytes compared with that in sham myocytes. Treatment with 50 mg/kg amiodarone inhibited I peak , however, treatment with 30 mg/kg matrine restored I peak to levels observed in shamoperated controls. I to density-voltage relationship was summarized in Fig. 3B . I to density at ϩ40 mV was significantly reduced from 17.94Ϯ1.41 pA/pF (nϭ19) in sham myocytes to 15.43Ϯ0.77 pA/pF in MI myocytes (nϭ18, pϽ0.05). I to density was decreasd to 10.54Ϯ1.41 pA/pF in rat treated with 50 mg/kg amiodarone 3 months (nϭ18, pϽ0.05), but treatment with 30 mg/kg matrine produced a marked increase in I to density to 19.28Ϯ0.74 pA/pF (nϭ16, pϽ0.05) compared with MI myocytes. Kv4.2 level was indeed significantly reduced in MI rats compared to sham rats in Fig. 3C (nϭ8, pϽ  0.05) . Western blot analysis indicated that the level of Kv4.2 channel protein was reduced in peri-ischemic zone ventricular myocardium, consistent with the reduction in I to . Matrine can obviously recovered the decreased Kv4.2 protein induced by MI (nϭ8, pϽ0.05).
Long-Term Effects of Matrine and Amiodarone on I K1 and Kir2.1 Protein Changes of I K1 were obtained from sham, MI, AmioϩMI, and MatϩMI groups. Our data showed that the reduction of I K1 current density was confirmed in ventricular cardiomyocytes of MI rat. More potent I K1 reduction was also observed in AmioϩMI group at test potential from Ϫ120 to Ϫ90 mV (nϭ17, pϽ0.05), however, in sharp contrast matrine restored the I K1 reduction to the level observed in sham rats (nϭ16, pϽ0.05, Fig. 4 ). The inwardly rectifying potassium channel Kir2.x subfamily members primarily mediate cardiac I K1 , Kir2.1 being the major component in both cardiac chambers. Figure 4C showed Western ] i was further investigated in Fluo-3/AM loaded cardiac myocytes and cells were stimulated with KCl in standard Tyrode's solution from different four groups (Fig. 5) . Intracellular calcium overload has been considered an underlying mechanism of cardiac myocytes injury during early ischemia/reperfusion. While in MI myocytes, the response of myocytes in four groups to KCl were quite different. The area under the curve of averaged ratio of fluorescence (FI/FI 0 ) was reduced to 89.2Ϯ3.3 in 3 months MI myocytes (nϭ23 from 8 rats, pϽ0.05), and 79.9Ϯ2.9 in AmioϩMI groups (nϭ25 from 8 rats, pϽ0.05) compared with 106.6Ϯ3.9 in sham group (nϭ14 from 6 rats). The average data showed that the area under the (FI/FI 0 ) curve in MatϩMI was not changed compared with that from sham group, but significantly larger than that from both MI and AmioϩMI rats respectively (nϭ33 from 8 rats, pϽ0.05). 
DISCUSSION
After post-infarction, hearts generally undergo hypertrophy with significant cellular and molecular remodeling of both the left and right ventricles resulting in functional and biochemical alterations of the myocardium. 17) This remodeling exacerbates cardiac function and is one of leading causes for arrhythmias. Ventricular arrhythmias were frequently observed after post-infarction, especially, spontaneous or induced ventricular tachyarrhythmias and fibrillation, which have been reported to occur in the rat model in the late post-MI phase. Most of sudden cardiac deaths are thought to be due to ventricular arrhythmias. In our present study matrine and amiodarone have also been shown to prevent ventricular arrhythmias in vivo after long-term administration in rats model of MI. Our data also demonstrated that the antiarrhythmic effect of matrine in lowering cardiovascular risk is superior to amiodarone following post-MI.
The action potential is a key determinant of cardiac electrical activity and shaped by different ion channel currents and ion transporters. The prolongation of action potential duration and ventricular arrhythmias are the characteristics of normal-zone tissues from post-infarction rat hearts. 18) After MI, the noninfarcted myocardium undergoes significant hypertrophy and this hypertrophic response of remodeled myocardium provokes an arrhythmogenic substrates, including APD prolongation, regional differences in APD, 17) and increased tendency to early after depolarization (EAD)-triggered activity and reentrant tachyarrhythmias. 19 ) I to is a major repolarizing current in many cardiac cells. I to carried primarily by K ϩ channels controls the early repolarization phase 1. A reduction in the amplitude of I to may contribute to action potential prolongation and arrhythmia in heart failure. 20, 21) It was reported that the prolongation of APD in the hypertrophic myocytes from rats after MI was due partly to the reduction of current density of both I to-f and I to-s . 22) These were similar to our results, moreover, Western blot analyses revealed a reduction of Kv4.2 protein in MI. Thus the decreased K ϩ channel expression was largely responsible for the prolonged APD. Cardiac I K1 current is a strongly inwardly rectifying K ϩ selective current and plays an important role in shaping the normal action potential.
23) The cardiac I K1 stabilizes the resting membrane potential and is responsible for shaping the initial depolarization and final repolarization of the action potential. 24, 25) Studies show I K1 plays a role in ventricular arrhythmias, highlighted by the recently described Andersen's syndrome and studies in the guinea pig heart model of ventricular fibrillation. 26) The results of the present study indicated that I K1 current density and the level of Kir2.1 protein were downregulated by MI, which was in accordance with previous studies. 27) We further focused on the properties and effects of matrine and amiodarone on post-infarction rat hearts. The most striking finding of our study is that matrine obviously restored the decreased I to /Kv4.2 protein and I K1 /Kir2.1 protein in post-MI rat ventricular myocytes, suggesting that it may be one of likely mechanisms that matrine modulates electrical remodeling. However, long-term treatment of amiodarone, a class III anti-arrhythmic agent, not only reduced I Ks but also inhibited I to , I K1 in MI rats. Matrine corrected prolongation of APD perhaps by restoring the decreased I to and I K1 in MI rats ventricular myocytes, while amiodarone failed to do so. This may explain the reason why long-term treatment matrine can reduce cardiovascular mortality significantly.
The prolonged APD in post-MI myocytes could be explained by the marked decrease in the density of the two outward K ϩ currents (I K1 and I to ) rather than by changes in the density or kinetics of the L-type Ca 2ϩ current. 17, 27) These results suggested that K ϩ channel down-regulation is the primary determinant of APD. Furthermore, the prolonged APD provides longer time frame for Ca 2ϩ influx and Ca 2ϩ release from sarcoplasmic reticulum (SR), which may take part in unbalance of the Ca 2ϩ handling. And impaired Ca 2ϩ uptake by SR in hypertrophic cells favors the occurrence of DADs, which associated with increased incidences of arrhythmias in post-MI rats.
Cytosolic calcium overload often occurs in acute myocardial ischemia/reperfusion injury. Impaired Ca 2ϩ uptake by SR and decay of Na ] i in normal guinea pig myocytes, and increased the effect on I Ca-L channel, moreover moderately prolonged APD. 4, 6, 7, 34) It was likely that matrine increased [Ca 2ϩ ] i by elevating the influx of Ca 2ϩ through Ltype Ca 2ϩ channel. Our observation supported the hypothesis that matrine administration had direct beneficial effects on contractile function in myocytes from 3 months myocardialinfarction rats.
In conclusion, this anti-arrhythmic profiles of matrine differed from those of class III drugs amiodarone. These results indicated that long-term matrine treatment improved cardiac function in myocardial-infarction heart not only by restoring the reduced I to , but also by recovering the decreased I K1 in myocardial-infarction cardiomyocytes, and by restoring the depressed amplitude of [Ca 2ϩ ] i in MI myocytes as well. The new insights that we have obtained from this study will help in the development of safer and more effective drugs.
